Sign in
Enrolling by invitationPhase 2

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Key facts

Who runs it
Nichole Doyle
Where
Kansas City, United StatesSee the site
Trial code
Status
Enrolling by invitation
Phase
Phase 2
People taking part
46 people, planned
Started
1 Jul 2024
Expected to end
Jul 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Dexmedetomidine
  • Normal Saline
Record updated
5 October 2026

Who can take part

Age
10 years to 21 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Diagnosis of idiopathic scoliosis
  • Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement

Who cannot take part

  • Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids
  • Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively
  • Moya Moya disease
  • Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 10 and 21 years old?

Where in United States

  • Children's Mercy HospitalKansas City, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.

The 2 groups in the trial

  • DexmedetomidineTreatment being tested

    Patient receives low dose dexmedetomidine infusion in addition to normal post-operative pain management protocol

  • ControlPlacebo, for comparison

    Patient receives normal saline infusion in addition to normal post-operative pain management protocol

    Treatment: Normal Saline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dexmedetomidine as a Pain Management Adjunct in the Pediatric Population Undergoing Posterior Spinal Fusion
Criteria questions
Built from NCT06067893, who can take part
Record updated
5 October 2026